Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials
Description
COVID-19 has highlighted the importance of studying differences by sex and gender. The underreporting of gender identity in COVID-19 studies limits the generalizability of study results to nonbinary persons. Some of the data on sex-assigned
